Literature DB >> 25110084

Study of fibrotic complications and hydroxyproline content in mouse liver at different stages of generalized BCG-induced granulomatosis.

V A Shkurupii1, L B Kim, O V Potapova, T V Sharkova, A N Putyatina, I K Nikonova.   

Abstract

Generalized BCG-induced granulomatous was simulated in BALB/c male mice. The number of tuberculous granulomas in the liver and their size as well as the number of hepatocytes showing vacuolar degeneration increased from day 3 to 180 postinfection. Necrotic changes in hepatocytes were most pronounced at the acute phase of inflammation (days 3 to 30). Proliferative processes in the liver parenchyma in the experimental group were less marked than in the control. Increased content of collagen fibers in the liver was determined by excessive collagen synthesis in necrotic areas as well as increased amount of granulomas and fibroblasts. Enhanced proliferative and fibroplastic activity of fibroblasts in granulomas and liver parenchyma was evidently determined by activated granuloma macrophages. These shifts determined changes in the liver content of hydroxyproline during the acute and chronic periods of the disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25110084     DOI: 10.1007/s10517-014-2592-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  5 in total

1.  Content of the Major Extracellular Matrix Components of the Liver and Lungs in Mice with Chronic BCG-Granulomatosis Treated with Liposome-Encapsulated Dextrazide.

Authors:  L B Kim; A N Putyatina; G S Russkikh; V A Shkurupy
Journal:  Bull Exp Biol Med       Date:  2021-03-16       Impact factor: 0.804

2.  Destructive Processes and Fibrotic Complications in the Liver of Mice with BSG-Induced Granulomatosis Treated with Anti-Tuberculous Drugs.

Authors:  V A Shkurupy; A M Sinyavskaya; A V Troitskii
Journal:  Bull Exp Biol Med       Date:  2021-03-13       Impact factor: 0.804

3.  In Vitro Study of the Expression of CD1, CD14, CD25, CD30, CD35, CD95 Receptors by Macrophages of Mice Infected with Mycobacterium tuberculosis.

Authors:  D A Il'in; V A Shkurupy; E S Akhramenko
Journal:  Bull Exp Biol Med       Date:  2021-11-19       Impact factor: 0.804

4.  Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis.

Authors:  Ya-Wen Zhang; Ling-Lan Tu; Yi Zhang; Jie-Chao Pan; Gao-Li Zheng; Li-Na Yin
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

5.  Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null Mice.

Authors:  Lucie Aumailley; Chantal Garand; Marie Julie Dubois; F Brad Johnson; André Marette; Michel Lebel
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.